Page 21 - Pharma Industry

These two bright minds have made Zeno Health a force to reckon with in Pharma industry

Founded by two IIT Bombay alumni, Mumbai based company Zeno Health is changing pharmaceutical industry.

Zydus Cadila Q4 net up 73% to Rs 679 cr, total income up a marginal 3%

During Q4FY21, firm launched Virafin to treat moderate infections in adult Covid-19 patients. Its ZyCoV-D plasmid DNA vaccine is at an advanced stage of Phase-3 trials

GST panel rejects demand for tax waiver on Covid-19 vax, ventilator

GST fitment panel has recommended a short-term rate cut on four Covid-19 related items

PharmEasy acquires Medlife, becomes India's largest e-pharma company

As Medlife discontinues operations, its users will move seamlessly to Pharmeasy, which will now serve 2 million households every month

Biotech cos Tzar Labs and Epigeneres to launch early-detection cancer tests

Firms claim breakthrough with their RNA-marker tech which detects cancer even in stage zero

Pharma sector's Q4 results show moderate gains amid Covid-19 pandemic

The ongoing April-June quarter should see strong growth due to low base of last year

Cipla open to forge a partnership to distribute Covid-19 vaccines in India

The company already makes and markets antiviral drugs like remdesivir, favipiravir in India apart from importing and distributing Roche's tocilizumab (Actemra)

Alembic Pharma Q4 net up 12% to Rs 251 cr on strong API, global businesses

Net sales rise 6% to Rs 1,280 cr; API business expands by as much as 38%

State govts begin vaccine price negotiations, eye Rs 150 per dose

States would have to fund procurement from their own budgets and bridge funding from the Centre is unlikely

Pharma poised for an excellent FY22 on the back of Covid-led demand

Improving exports and a weak rupee could support profit boost

Strong injectables portfolio to support Aurobindo Pharma's growth

The stock has been underperforming recent months and trades at a discount to peers

Shortage of key chemical hits Bharat Biotech's Covaxin ramp-up plans

Bharat Biotech is trying to ramp up capacities of Covaxin to 12 million doses per month by July, from the current 5 million doses per month

Alembic Pharma's injectables plant launch may face some delay

Company saw Form 483 with observations issued by US FDA for injectables plant in February

Piramal Pharma to acquire 100% stake in Hemmo Pharma for Rs 775 cr

Consequent to the acquisition, Hemmo Pharmaceuticals Pvt Ltd would become a wholly-owned subsidiary of Piramal Pharma Ltd

Orchid Pharma rises from ashes, expects to make profits in 12 months

Dhanuka Pharmaceuticals that took over the company almost a year ago, nursed it back to health from bankruptcy

Govt okays 33 API applications with Rs 5k cr investment under PLI scheme

In total, 215 applications have been received for the 36 products spread across the 4 target segments, the Ministry of Chemicals and Fertilizers said in the release

New launches, market share gains to sustain Gland Pharma's sales trajectory

Earnings are expected to grow over 25 per cent over the next two years

Healing a weak regulator

Weaknesses in India's drug regulatory regime and the constraints and questionable decisions of the drug regulator could mar the country's reputation in global markets

Pharma stocks may hold ground as volatility grips global markets

The Nifty Pharma index was down 1.76 per cent on Friday compared to a 568-point or nearly 3.8 per cent slide in the Nifty50 on weak global cues

Make next 10 years 'the decade of India': Piyush Goyal to pharma firms

Coining a new acronym, Goyal said the world today needs CURE - Cost-effective Uni­ve­rsal solutions through Research and Enterprise